286 related articles for article (PubMed ID: 2906508)
1. Somatostatin inhibits prolactin secretion by multiple mechanisms involving a site of action distal to increased cyclic adenosine 3',5'-monophosphate and elevated cytosolic Ca2+ in rat lactotrophs.
Bjøro T; Ostberg BC; Sand O; Torjesen PA; Penman E; Gordeladze JO; Iversen JG; Gautvik KM; Haug E
Acta Physiol Scand; 1988 Jul; 133(3):271-82. PubMed ID: 2906508
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
4. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells.
Gordeladze JO
Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of basal and corticotropin-releasing hormone-stimulated adenylate cyclase activity and cytosolic Ca2+ levels by somatostatin in human corticotropin-secreting pituitary adenomas.
Spada A; Reza-Elahi F; Lania A; Bassetti M; Atti E
J Clin Endocrinol Metab; 1990 May; 70(5):1262-8. PubMed ID: 1970828
[TBL] [Abstract][Full Text] [Related]
7. Adenosine inhibits prolactin and growth hormone secretion in a clonal pituitary cell line.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1985 Dec; 117(6):2330-8. PubMed ID: 2998734
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin inhibits basal and thyrotropin-releasing hormone-induced release of prolactin from anterior pituitary cells: evidence for a selective action exerted proximal to secretagogue-induced increases in cytosolic Ca2+.
Shah GV; Wang W; Grosvenor CE; Crowley WR
Endocrinology; 1990 Aug; 127(2):621-8. PubMed ID: 2115431
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the adenosine 3',5'-monophosphate and the Ca2+ messenger systems together reverse dopaminergic inhibition of prolactin release.
Delbeke D; Dannies PS
Endocrinology; 1985 Aug; 117(2):439-46. PubMed ID: 2990850
[TBL] [Abstract][Full Text] [Related]
10. Dependence of electrical activity and calcium influx-controlled prolactin release on adenylyl cyclase signaling pathway in pituitary lactotrophs.
Gonzalez-Iglesias AE; Jiang Y; Tomić M; Kretschmannova K; Andric SA; Zemkova H; Stojilkovic SS
Mol Endocrinol; 2006 Sep; 20(9):2231-46. PubMed ID: 16645040
[TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin blocks both cyclic AMP-mediated and cyclic AMP-independent actions of somatostatin. Evidence for coupling of Ni to decreases in intracellular free calcium.
Koch BD; Dorflinger LJ; Schonbrunn A
J Biol Chem; 1985 Oct; 260(24):13138-45. PubMed ID: 2865257
[TBL] [Abstract][Full Text] [Related]
12. Biphasic action of forskolin on growth hormone and prolactin secretion by rat anterior pituitary cells in vitro.
Szabo M; Staib NE; Collins BJ; Cuttler L
Endocrinology; 1990 Oct; 127(4):1811-7. PubMed ID: 1698147
[TBL] [Abstract][Full Text] [Related]
13. On the functional relationship between 45Ca2+ release and prolactin secretion in cultured rat pituitary tumour (GH3) cells.
Iversen JG; Sletholt K; Haug E; Gautvik KM
Acta Physiol Scand; 1986 Jun; 127(2):249-55. PubMed ID: 2873712
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin-releasing hormone rapidly stimulates a biphasic secretion of prolactin and growth hormone in GH4C1 rat pituitary tumor cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Jan; 116(1):73-82. PubMed ID: 3917255
[TBL] [Abstract][Full Text] [Related]
15. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of the inhibitory action of dopamine and somatostatin on prolactin secretion from human lactotrophs in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 Mar; 60(3):599-606. PubMed ID: 2579087
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of action of somatostatin on human TSH-secreting adenoma cells.
Takano K; Ajima M; Teramoto A; Hata K; Yamashita N
Am J Physiol; 1995 Apr; 268(4 Pt 1):E558-64. PubMed ID: 7733252
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of adrenocorticotropin secretion from AtT-20 cells by the calcium channel activator, BAY-K-8644, and its inhibition by somatostatin and carbachol.
Heisler S
J Pharmacol Exp Ther; 1985 Dec; 235(3):741-8. PubMed ID: 2416908
[TBL] [Abstract][Full Text] [Related]
19. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide and peptide with N-terminal histidine and C-terminal isoleucine increase prolactin secretion in cultured rat pituitary cells (GH4C1) via a cAMP-dependent mechanism which involves transient elevation of intracellular Ca2+.
Bjøro T; Ostberg BC; Sand O; Gordeladze J; Iversen JG; Torjesen PA; Gautvik KM; Haug E
Mol Cell Endocrinol; 1987 Feb; 49(2-3):119-28. PubMed ID: 2435588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
